The Re/Wire Health Studio from Haleon NEXT is on a mission to democratise access to everyday health care, create seamless health experiences, and improve health outcomes for consumers.

Haleon’s world-leading Consumer Health business combines science and consumer insights to create innovative everyday healthcare brands that consumers trust and experts recommend for oral health, pain relief, cold, flu and allergy, digestive health and vitamins, minerals and supplements.

Haleon NEXT will partner with participating startups to offer mentorship, R&D support, and commercialisation opportunities. The Haleon NEXT team will work directly with startups, and will help them navigate the resources of Haleon at large.

R/GA’s award-winning strategists, technologists, creatives, and consultants will advise the six startups selected for the Studio and prepare them for future milestones. Startups will have exposure and access to R/GA’s global client network and industry-spanning corporate partners. R/GA’s creative talent will be available to consult on startups’ presentations ahead of the presentations event at the end of the program.

Yes, applications will be considered on a rolling basis and selection for cohort 3 will take place September-October 2022. Cohort 3 will run from mid-October-December 2022.

The Re/Wire Health Studio is built to collaborate with startups building next generation solutions that can address evolving consumer needs. Each focus area is aligned with core ideas surrounding everyday health issues, including proactive care. Learn more about the three focus areas of opportunity above. Haleon NEXT is also interested in startups within the biomarker space both physical and biological.

1. Strategic partnership opportunities – working in depth with Haleon in order to facilitate opportunities for rapid global scale. These opportunities may be either commercial in market trials and partnerships or may be more R&D focused support and joint development.
2. Mentoring and networking – the studio is pulling together a panel of leaders, innovators, investors and entrepreneurs in the Consumer Health space

The Studio will identify strategic opportunities for startups to partner with Haleon and provide the selected Studio companies with the market opportunities, guidance, and partnerships to build momentum towards scaling globally. Selected startups will have access to R/GA’s creative capital services with award-winning strategists, technologists, creatives, and consultants to help them develop their businesses and prepare them for future milestones.

The Studio invites applications from innovative growth- and early-stage companies with disruptive technologies that will shape the future of consumer health. The Studio welcomes applications from startups with pre-seed through Series A funding.

Haleon NEXT welcomes startups from around the world to apply, but must be capable and prepared to launch in the U.S. and/or EMEA with a minimum viable product or service in development or in-market.

Investment is not a component of the Studio; however, Haleon NEXT may seek to invest in participating startups after the conclusion of the program. Participation in the program is not contingent upon the possibility of future investment, and Haleon NEXT will not seek the right to invest as part of the program.

All Studio participation and programming will be done virtually. Founders are not required to relocate themselves or their team to participate.

No, there is no fee or equity charge to apply or participate in the Re/Wire Health Studio.

Applications will be considered on a rolling basis. Selected candidates will be invited to participate in workshops with Haleon stakeholders in September 2022 for consideration for cohort 3. Cohort 3 runs from mid-October-December 2022.

Finalists will be selected based on quality of product or service (or path to product or service), robustness of business model, strength of team, and alignment with Haleon NEXT’s objectives. Selected companies will go through a technical and business due diligence process.

Participation in other accelerator programs will not exclude startups from the Re/Wire Health Studio, but preference will be given to companies that can devote the time required to pursue the full range of opportunities delivered by the Studio. Startups that have active or past partnerships or commercial engagement with competitors of Haleon may not be eligible to participate.

Haleon is a science-led global healthcare company with a special purpose: to help people do more, feel better, and live longer. For further information please visit https://www.haleon.com/who-we-are.

Haleon NEXT is the strategic commercial growth engine for Haleon Consumer Health, focused on the creation and scaling of net-new product, service and platform businesses across Everyday Health.

R/GA designs businesses and brands for a more human future. A leader in technology and creativity for more than 40 years, R/GA has expanded and evolved its capabilities in anticipation of technology’s impact on its clients’ businesses to offer services through our award-winning consulting, Ventures, technology, design, communications, and IP practices.

R/GA Ventures helps corporate leaders identify and capitalise on disruptive technologies and emerging behaviors while supporting startups with financial and creative capital to drive growth and returns. Our expertise in the startup ecosystem, coupled with our experience transforming Enterprise businesses, allows us to identify, develop, and test solutions to close the corporate innovation gap. We exist to test new products, services, and business models to fuel new waves of growth for our clients.